Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease
Status:
Withdrawn
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, tolerability, and PK following a single
administration of BPS804 in patients with chronic kidney disease stage 5D (CKD-5D) on
hemodialysis.